Content
71%Weight 40%Scale 1-5Reviews the quality of instructions and guidance provided to agents. Good implementation is clear, handles edge cases, and produces reliable results.
The body is well-structured with strong progressive disclosure (a clean overview table routing to four verified, well-organized reference files) and largely actionable templates and checklists. Its weakest area is token efficiency: it restates concepts Claude already knows and carries a time-sensitive enforcement-news section that inflates the overview and will age quickly.
Suggestions
Trim or relocate basic-concept restatements (the PHI definition, TPO explanation, and "Tone & Approach" section) that Claude can already infer, keeping only the domain-specific specifics like CFR citations and the 18-identifier enumeration.
Move the September 2026 enforcement-and-rulemaking news (settlement names, dollar amounts, Unified Agenda dates) into a dedicated dated reference file or a clearly bounded "Regulatory status" appendix so the overview stays lean and the volatile content can be updated in one place.
Add a brief pre-delivery validation step to each workflow (e.g., confirm the disclaimer is included and every cited regulation uses the `45 CFR §164.[section]` format) to close the workflow-clarity validation gap.
| Dimension | Reasoning | Score |
|---|---|---|
Conciseness | Well-organized but includes material Claude already knows (e.g., "PHI = Individually identifiable health information…", TPO definitions), an inferable "Tone & Approach" section, and a dense time-sensitive enforcement-news block with specific 2025–2027 dates and dollar amounts not placed in a deprecated/status-style section — per the rubric this costs conciseness. Fits "mostly efficient but could be tightened," not the noticeably-verbose anchor 2. | 3 / 5 |
Actionability | Provides copy-paste-ready output skeletons (structured review template with issue table and risk levels; technical assessment checklist with exact citations like "§164.312(a)(2)(i)") and specific requirements ("AES-256 at rest, TLS 1.2+ in transit", "[ORGANIZATION NAME]" placeholders). Falls short of anchor 5 only because no worked finished example is shown and a few directives remain abstract ("Use concrete examples relevant to the user's context"). | 4 / 5 |
Workflow Clarity | Each use case has a clear sequence ("1. Identify scope… 2. Load relevant reference files 3. Structured review output") with checklist-style checkpoints (the mandatory disclaimer, the "Always:" requirements for document generation). Minor validation gaps — no step confirming citations/disclaimer before delivering output — keep it at anchor 4 rather than 5. | 4 / 5 |
Progressive Disclosure | The body is a clear overview with a "When to load" table pointing to four real, one-level-deep reference files (all verified present on disk), with bulk detail appropriately split into them and easy navigation — matching the top anchor. The inline "Key HIPAA Concepts" section is a compact distillation, not misplaced bulk detail. | 5 / 5 |
Total | 16 / 20 Passed |